Use Case · Selective Antioxidant
Why molecular hydrogen behaves differently from every antioxidant in your cupboard.
The selective antioxidant
Most antioxidants are blunt instruments. They neutralise every free radical they meet — including the ones your body uses on purpose. Molecular hydrogen targets only the most damaging, and leaves the useful ones alone. That selectivity is the reason the research has moved as far as it has.
Walk down the antioxidant aisle of any health-food shop and you’ll see a row of bottles all promising roughly the same thing. Vitamin C. Vitamin E. Astaxanthin. Resveratrol. Coenzyme Q10. The packaging is confident. The science, when you look closely, has grown quieter than it used to be.
Two decades of large trials have made a difficult thing clear: indiscriminate antioxidant supplementation does not reliably do what the supplement industry implies it does. Some studies have shown no benefit. A handful have shown harm — high-dose vitamin E in particular. Researchers started calling it the antioxidant paradox: if oxidative stress is the problem, why doesn’t loading the system with antioxidants reliably fix it?
The answer, the research now suggests, is that the body uses some free radicals on purpose. Hydrogen peroxide is part of how immune cells signal. Superoxide is part of how exercise adaptation works. Nitric oxide is part of how blood vessels regulate themselves. A blunt antioxidant that mops up every reactive species it meets is not helping — it’s interrupting messages the body is trying to send.
Which raises a quieter question. What would an antioxidant look like if it were selective? If it only neutralised the radicals doing genuine harm, and left the signalling radicals alone to do their work?
In 2007, a research group at Nippon Medical School in Tokyo proposed in Nature Medicine that exactly such a molecule exists, and that it is the smallest one in the universe. Their paper is one of the most-cited papers in the field. It opened a field that now spans hundreds of studies. And it is the reason a wellness category that did not exist twenty years ago exists now.
This page is about what they found, and why it changes how the antioxidant question is asked.
New to molecular hydrogen? Start with what is hydrogen therapy.
The Research
What the research suggests.
In June 2007, Ohsawa and colleagues published a paper in Nature Medicine titled, with quiet confidence, “Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals”. The work had two parts. In cell culture, they induced oxidative stress through three independent methods and showed that molecular hydrogen reduced the hydroxyl radical — the most cytotoxic reactive oxygen species — without reacting with the reactive species the cell uses for normal signalling. In a rat model of focal ischaemia and reperfusion, inhaled H2 gas markedly reduced brain injury. The proposed mechanism: selective scavenging of the hydroxyl radical and peroxynitrite, the two reactive species the body has no controlled use for, while leaving signalling radicals untouched (Ohsawa et al., Nature Medicine 2007;13:688–94).
Seven years later, Shigeo Ohta — head of the group that produced the 2007 paper — published a review in Pharmacology & Therapeutics taking stock of what had followed. The field had grown from a single proposed mechanism to a research literature spanning a wide range of diseases, physiological states and clinical tests across leading journals. The selective-antioxidant mechanism was holding up. Additional mechanisms had been added to the picture — signalling modulation, anti-inflammatory effects, and engagement with the Nrf2 cellular-defence pathway — but selectivity remained the foundational property that made the rest of it possible (Ohta, Pharmacology & Therapeutics 2014;144:1–11).
A year after that, Ichihara and colleagues published the most comprehensive accounting of the field to date — a review of 321 original research articles on the biological effects of molecular hydrogen published between 2007 and mid-2015 (Ichihara et al., Medical Gas Research 2015;5:12). Most were animal or cell-culture work. A growing minority were human clinical trials. The breadth of physiological systems in which hydrogen showed activity — neurological, cardiovascular, metabolic, inflammatory, respiratory — was striking enough that the review’s authors stopped trying to list them and started grouping them into categories.
That is where the research stands at a high level. Worth saying clearly: the foundational work is preclinical. The mechanism is well-supported in primary literature. The translation from “this is how the molecule behaves” to “this is what happens in healthy human adults” is the work the field is still doing. We think both halves of that sentence matter.
The Mechanism
How the selectivity actually works.
To understand selectivity, it helps to start with the thing most antioxidant marketing skips over: not all free radicals are bad.
Cellular signalling uses reactive oxygen species deliberately. Hydrogen peroxide functions as a messenger between cells. Superoxide is part of how the immune system identifies and destroys pathogens. Mitochondria produce a low background level of reactive species as a normal byproduct of energy generation, and the cell reads that background as information — a signal about how hard it is working and what adjustments it should make. Blanket antioxidants do not know any of this. They scavenge what they can reach.
What the body genuinely cannot tolerate is the hydroxyl radical. It is the single most cytotoxic reactive oxygen species. It has no useful signalling function. It is indiscriminate in what it damages — DNA, lipids, proteins, mitochondrial membranes. Peroxynitrite, formed when superoxide reacts with nitric oxide, sits in the same category: damaging, with no controlled physiological purpose.
Two physical properties of molecular hydrogen make it different from every other antioxidant on the shelf. The first is size. H2 is the smallest stable molecule in the universe — two hydrogen atoms, no charge, electrically neutral. It can diffuse passively across cell membranes, into the mitochondrial matrix, into the nucleus, into the lipid interior of cell membranes themselves. Vitamin C, by contrast, is water-soluble and stays in aqueous compartments. Vitamin E is fat-soluble and stays in membranes. Neither can reach where H2 can reach.
The second property is reactivity. H2 is thermodynamically capable of reducing the hydroxyl radical and peroxynitrite. It is largely inert toward hydrogen peroxide, superoxide, and nitric oxide — the reactive species the body uses for signalling. The selectivity is not a marketing claim. It is a property of the molecule’s electron structure, and it is the central finding of the foundational research.
The net effect, the research suggests, is a molecule that can sit quietly inside cells, leave normal physiology undisturbed, and react only when the most damaging oxidants appear. What the molecule does is established. What the person feels from a daily practice is the question the next section turns to.
What It Feels Like
Why the science feels like it matters.
The 2007 Nature Medicine paper is the moment hydrogen moved from being a gas long assumed to be biologically inert to being a molecule worth a serious researcher’s time. The paper was modest in tone. It proposed a mechanism, demonstrated it in two model systems, and stopped. It did not promise cures. It did not announce a revolution. It simply asked the field to look more carefully at a molecule everyone had previously dismissed.
The field looked. By 2015, more than 300 original research papers had been published on H2’s biological effects. By 2026, that number is several times higher. The mechanism has held up under scrutiny. Additional mechanisms have been added to the picture. The clinical translation work is ongoing.
The reason that history matters to a person, and not just to a chemist, is this. Selectivity suggests a way to address oxidative stress without disturbing the parts of physiology that depend on controlled oxidation. The exercise adaptation. The immune signalling. The mitochondrial housekeeping. Many users report that the practice settles into the day quietly — they don’t feel a peak, they feel a baseline shift over weeks. Not a stimulant. Not a sedative. A quiet adjustment to how the system handles its own internal weather.
It is the difference between a switch and a thermostat. Most antioxidant strategies act like a switch — flip it on, scavenge everything. Selective antioxidant behaviour, the research suggests, acts more like a thermostat. Present. Attentive. Reacting only when the system asks.
Subjective experience varies. The research is preclinical mechanism work, plus a growing body of clinical work in healthy adults. We’ve written about both elsewhere on the site.
Daily Practice
What the daily practice looks like.
If selectivity is how the molecule behaves, what does the actual session look like?
A typical session runs 30 to 60 minutes once daily. Some users run 90 minutes during periods of higher demand — after harder training weeks, around travel, in winter. The research on optimal inhalation duration is still settling. We don’t claim a single right answer.
The flow rate question is where the published research gives a useful steer. Most peer-reviewed inhalation studies cluster between 250 and 600 ml/min of H2 delivery. The Hydro Nova produces 1,500 ml/min — at the dose serious research uses, not the minimum that has been tested. The reasoning is straightforward: if a 300 ml/min dose has produced measurable effects in published trials, a 1,500 ml/min device is operating well above that floor rather than at it.
The practice itself asks nothing of you. Cannula on, machine running, the rest of the day continuing. No breathing exercise. No posture. No protocol. Most users sit and read, or work, or watch something. The session runs alongside whatever the rest of the hour was going to be.
That is, in the end, the practical answer to the mechanism question. The molecule does its work at the cellular level. The person does whatever they were going to do. The two run quietly in parallel.
Daily practice. The work happens quietly.
Is This Right For You?
Right for you if the mechanism matters as much as the marketing.
This isn’t a cure. It isn’t a treatment for any condition. It isn’t medicine. What it is, for the people it suits, is a research-backed daily practice built on what may be the most carefully described antioxidant mechanism in current wellness science.
Most of the original research is preclinical — cell cultures and animal models. The mechanism is well-supported in primary literature. The human translation is the work the field is still doing, and we’d rather say that out loud than overclaim. Our careful language is part of why our customers trust us.
This is the page for the reader who wants to understand the why. The chemistry behind the practice. The reason a 2007 paper in a serious journal moved researchers around the world to look at hydrogen seriously. If you’ve been sceptical of antioxidants generally — and there are good reasons to be — the selectivity question is the one worth your time.
The Hydro Nova was specified at 1,500 ml/min because that’s where the serious research lives. Same molecule, same mechanism, delivered at a flow rate the literature actually studies. We think that matters.